SEI BELLA CLARITY CLEAR REFINING FOAMING CLEANSER ACNE TREATMENT- salicylic acid liquid

Sei Bella Clarity Clear Refining Foaming Cleanser by

Drug Labeling and Warnings

Sei Bella Clarity Clear Refining Foaming Cleanser by is a Otc medication manufactured, distributed, or labeled by Melaleuca, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Salicylic Acid 1%

Purpose

Acne treatment

INDICATIONS & USAGE

Uses

• treats acne
• clears acne blemishes
• helps control development of new blemishes

Warnings

For external use only

Do not get into eyes. If contact occurs, rinse eyes thoroughly with water.

WHEN USING

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If this occurs, only one medication should be used unless otherwise directed by a doctor.

STOP USE

Stop use and ask a doctor if excessive irritation of the skin develops.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION

Directions

• wet face
• pump dispenser 2-3 times onto palms of hands
• massage onto the face avoiding the eye area
• use morning and night
• if excessive drying of the skin occurs, start with one application daily and then gradually increase if needed
• if bothersome peeling or dryness occurs, reduce application to once a day or every other day

INACTIVE INGREDIENT

Aqua (Water/Eau), Sodium Cocoyl Glutamate, Glycerin, Lauroyl/Myristoyl Methyl Glucamide, Pyrus Malus Fruit Extract, Coco-Betaine, Niacinamide, Panthenol, Salicylic Acid, Sodium Polyacrylate, Benzyl Alcohol, Capryloyl/Caproyl Methyl Glucamide, Coco-Glucoside, Glyceryl Oleate, Citric Acid, Ethylhexylglycerin, Trisodium Ethylenediamine Disuccinate, Chlorella Vulgaris, Extract, Tocopherol

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SEI BELLA CLARITY CLEAR REFINING FOAMING CLEANSER  ACNE TREATMENT
salicylic acid liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 54473-401
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	1.8 g  in 180 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
TOCOPHEROL (UNII: R0ZB2556P8)
BENZYL ALCOHOL (UNII: LKG8494WBH)
PANTHENOL (UNII: WV9CM0O67Z)
GLYCERYL OLEATE (UNII: 4PC054V79P)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)
APPLE PEEL (UNII: MA36MNW77O)
COCO-BETAINE (UNII: 03DH2IZ3FY)
COCO GLUCOSIDE (UNII: ICS790225B)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q)
LAUROYL/MYRISTOYL METHYL GLUCAMIDE (UNII: SC667B999P)
SODIUM COCOYL GLUTAMATE (UNII: BMT4RCZ3HG)
CAPRYLOYL/CAPROYL METHYL GLUCAMIDE (UNII: 0451R360HR)
CHLORELLA VULGARIS (UNII: RYQ4R60M02)
NIACINAMIDE (UNII: 25X51I8RD4)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 54473-401-01	180 mL in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product	01/01/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	01/01/2024

Labeler - Melaleuca, Inc. (139760102)

Registrant - Melaleuca, Inc. (079711683)

Establishment
Name	Address	ID/FEI	Business Operations
Melaleuca, Inc.		079711683	manufacture(54473-401)